The current pandemic coronavirus, SARS-CoV-2, is a global health emergency because of
its highly contagious nature, the great number of patients requiring intensive care therapy …

Background For many chronic immune system disorders, the available treatments provide
several options for route of administration. The objective of this systematic literature review is …

Accurate and timely diagnosis of primary immunodeficiencies (PID) is an ongoing effort.
Individuals with PID can be severely impacted by their disease and many experience …

Subcutaneous (SC) drug delivery can be a safe, effective alternative to the traditional
intravenous route of administration, potentially offering notable advantages for both patients …

We have read with interest your editorial [1]. Indeed, the pandemic infection coronavirus
disease 2019 (COVID-19), caused by the new coronavirus named severe acute respiratory …

Immunoglobulin replacement therapy is the standard-of-care treatment for patients with
primary immunodeficiency diseases who have impaired antibody production and function …

Primary immunodeficiencies (PIDs) are immune disorders resulting from defects in genes
involved in immune regulation, and manifesting as an increased susceptibility to infections …

This evidence‐based clinical guideline provides consensus‐recommendations for the
treatment and care of patients with primary antibody deficiencies (PADs). The guideline …

Objective We assessed the health-related quality of life (HRQoL) in CVID adults receiving
different schedules of immunoglobulin replacement therapy (IgRT) by intravenous (IVIG) …

Background Current treatments for hemophilia A in Canada include on-demand treatment
as bleeds occur and regular intravenous prophylactic factor VIII (FVIII) infusions. The …